• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德里东部结核分枝杆菌的初始耐药性和获得性耐药性

Initial and acquired drug resistance of Mycobacterium tuberculosis in east Delhi.

作者信息

Mahajan M, Agarwal D S, Gadre D J, Singh N P, Gupta H C, Talwar V

机构信息

Department of Microbiology, University College of Medical Sciences, New Delhi.

出版信息

J Commun Dis. 1996 Mar;28(1):15-9.

PMID:8778175
Abstract

One hundred and fifty six strains of Mycobacterium tuberculosis, isolated from cases of pulmonary tuberculosis were subjected to sensitivity test to detect initial and acquired drug resistance to Streptomycin, isoniazid, Rifampicin, Ethambutol and Pyrazinamide. Initial and acquired drug resistance was observed to one or more drugs in 16% and 24.4% of the patients respectively. Strains resistant to Rifampicin and Ethambutol were resistant to Isoniazid also. Drug resistance was unrelated to age and sex of the patients.

摘要

从肺结核病例中分离出156株结核分枝杆菌,对其进行药敏试验,以检测对链霉素、异烟肼、利福平、乙胺丁醇和吡嗪酰胺的初始耐药性和获得性耐药性。分别在16%和24.4%的患者中观察到对一种或多种药物的初始耐药性和获得性耐药性。对利福平和乙胺丁醇耐药的菌株对异烟肼也耐药。耐药性与患者的年龄和性别无关。

相似文献

1
Initial and acquired drug resistance of Mycobacterium tuberculosis in east Delhi.德里东部结核分枝杆菌的初始耐药性和获得性耐药性
J Commun Dis. 1996 Mar;28(1):15-9.
2
Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).德里结核病的耐药性:两年概况(2001 - 2002年)
J Commun Dis. 2003 Jun;35(2):74-81.
3
Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.新痰涂片阳性的印度国家结核病控制规划(RNTCP)患者中结核分枝杆菌初始耐药的患病率。
J Commun Dis. 2003 Jun;35(2):82-9.
4
Drug resistance to the first line of antitubercular regimen (a preliminary report).对一线抗结核治疗方案的耐药性(初步报告)。
Indian J Public Health. 1998 Oct-Dec;42(4):126-30.
5
[Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon].[喀麦隆雅温得结核分枝杆菌复合群对主要抗结核药物的耐药性]
Bull Soc Pathol Exot. 1998;91(3):199-202.
6
Anti-tuberculosis drug resistance in the West Province of Cameroon.喀麦隆西部省的抗结核药物耐药性
Int J Tuberc Lung Dis. 2000 Apr;4(4):356-60.
7
A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.1984 - 1987年马来西亚西部肺结核原发性耐药性研究
Med J Malaysia. 1993 Jun;48(2):113-6.
8
Drug resistant tuberculosis in Estonia.爱沙尼亚的耐药结核病
Int J Tuberc Lung Dis. 1998 Feb;2(2):130-3.
9
[A case of multidrug-resistant tuberculosis who acquired additional resistance to ethambutol before the result of the initial drug sensitivity test was reported].1例耐多药结核病患者在初始药敏试验结果报告前对乙胺丁醇产生了额外耐药性
Kekkaku. 2010 Aug;85(8):679-82.
10
Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania.坦桑尼亚达累斯萨拉姆新诊断肺结核病例中分离出的结核分枝杆菌的抗结核药物耐药水平及模式
APMIS. 2009 Apr;117(4):263-7. doi: 10.1111/j.1600-0463.2008.02429.x.

引用本文的文献

1
MULTIDRUG RESISTANT TUBERCULOSIS - BIOMECHANISM, EPIDEMIOLOGY AND MANAGEMENT STRATEGIES.耐多药结核病——生物机制、流行病学及管理策略
Med J Armed Forces India. 1997 Jul;53(3):207-213. doi: 10.1016/S0377-1237(17)30717-7. Epub 2017 Jun 26.